BVT Call 36 FRE 21.02.2025/ DE000VC9Z1Y6 /
1/23/2025 7:45:10 PM | Chg.+0.600 | Bid9:58:12 PM | Ask9:58:12 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.580EUR | +61.22% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 36.00 EUR | 2/21/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil